Elucid

Join us at our next live webinar on November 6th, 2024 as Dr. Amir Ahmadi, MD (Mount Sinai) and Dr. Jagat Narula MD PhD (UTHealth Houston) discuss the importance of histology-based plaque analysis, plaque composition (i.e., lipid rich necrotic core), varying vulnerabilities and underlying implications as it relates to heart attack risk and atherosclerosis prevention and treatment. Additional topics include application of AI plaque analysis softwares in practice, and how it addresses a current gap in cardiovascular care, referred to, in this session, as the MI paradox. Treatment plans based on actual disease evidence vs. population-based risk, impact of technology on future care programs, will be explored. In partnership with Society of Cardiovascular Computed Tomography Register for free: https://lnkd.in/g9YRnGMe

We're ready for the Southwest Florida Cardiovascular Imaging Symposium happening this weekend! Looking forward to a fantastic agenda jam-packed with great sessions. Come visit our booth and stop by our session on Saturday 3:35 PM led by Dr. Amir Ahmadi. Thank you to Drs. Shone Almeida, MD, FACC and James J. Thompson for organizing. #YesCCT #PlaqueAnalysis #HistologyMatters #PlaqueIQ

It’s not too late to register and join us this afternoon at 1PM ET! Hear about the importance of plaque detection in CT plaque analysis, the clinical relevance of LRNC (lipid rich necrotic core), and how #YesCCT can take us further in personalizing care for CAD treatment. See you there! #CTFirst #PlaqueAnalysis #HistologyMatters

Fantastic news - CMS will double the amount paid to hospitals and outpatient clinics who perform cardiac CT scans from $175 to $357.13, allowing more hospitals, particularly those in non-urban areas, to be able to offer this service, reducing disparities in care. To read more: https://lnkd.in/gPMb8W7m Hats off to Society of Cardiovascular Computed Tomography for the years of advocacy and dedicated work to bring this to reality. #YesCCT is at an unprecedented time, and we're thrilled to see the ongoing developments that are bound to change clinical care and impact patient experience.

This is incredible news. A huge win for physicians, patients, and the leadership teams pushing this movement forward.

❗ Next Wednesday at 1PM ET! ❗ Register: https://lnkd.in/g9YRnGMe Join us at our live webinar on November 6th, 2024 as Dr. Amir Ahmadi, MD (Mount Sinai) and Dr. Jagat Narula MD PhD (UTHealth Houston) discuss the importance of histology-based plaque analysis, plaque composition (i.e., lipid rich necrotic core), varying vulnerabilities and underlying implications as it relates to heart attack risk and atherosclerosis prevention and treatment. Free registration in partnership with Society of Cardiovascular Computed Tomography

This past weekend, Elucid supported American Heart Association’s Boston Heart Walk. 🍁 🍂 A perfect autumn day to get the team together and support a great cause! Happy 100 years, AHA 🫀 #TeamElucid #WhatsYourPlaqueIQ

Thank you for having Dr. Ahmadi and hosting such a great discussion on the power of plaque analysis and tracking progression of vulnerable plaque types such as lipid rich necrotic core. Always a great conversation! Society of Cardiovascular Computed Tomography

More news! 📰 Read here: https://lnkd.in/gU7Bg_ra 🫀 We are happy to share that Noridian is the latest Medicare Administrative Contractor (MAC) to extend coverage for ElucidPlaqueIQ, beginning December 8, 2024. With this decision, five of the seven MACs will soon provide coverage for AI-enabled quantitative coronary plaque analysis, expanding accessibility to over 70 percent of eligible Medicare patients across the United States. Ask us about how ElucidPlaqueIQ's histology-derived, FDA-cleared plaque analysis software can be implemented in your CT program! #AI #ElucidNews #PlaqueAnalysis #YesCCT #CTFirst

Exciting news for AI-Coronary Plaque Analysis! Four MACs have released updated LCDs for CPT codes 0623T-0626T, making AI-CPA using CCTA a covered diagnostic study. Learn more: https://ow.ly/jfix50TM5h5